AUS
NZ
UK
CA
USA
IND
Healthcare
Are SHL Shares Being Overlooked as ASX 200 Momentum Builds?
November 20, 2025 12:17 PM AEDT| By SamSonic Healthcare and Xero navigate shifting market sentiment while maintaining strong long-term positions within healthcare and digital finance, underscoring their continued relevance across Australia’s evolving economic landscape.
EMA backs PTX-100 breakthrough as Prescient Therapeutics advances beyond ASX 200
November 19, 2025 12:59 PM AEDT| By SamPrescient Therapeutics advances PTX-100 following orphan designation, strengthening its regulatory direction, clinical progress, and strategic development within targeted oncology, with continued focus on rare lymphoma conditions.
Breakthrough Cancer Screening Advances as BCAL Diagnostics Expands Reach
November 19, 2025 12:55 PM AEDT| By SamAustralia prepares for new blood-based cancer detection tools as BCAL advances clinical integration, expanded screening pathways, and telehealth support to strengthen early diagnostic access nationwide.
COG Financial Services Faces Market Pressure as Ownership Structure Shifts
November 19, 2025 11:59 AM AEDT| By SamCOG Financial Services experiences heightened attention as shifting ownership dynamics prompt fresh analysis. Public, institutional, insider, and private stakeholders collectively shape sentiment and long-term structural direction across the Australi...
All Ordinaries Spotlight on Proteomics International Laboratories and Its Biotech Funding Structure
November 18, 2025 04:27 PM AEDT| By SamExtensive assessment of funding utilisation, scientific operations and expenditure patterns for Proteomics International Laboratories within the All Ordinaries biotechnology sector.
Sonic Healthcare Limited Strengthens Diagnostic Capacity Across ASX 100 Healthcare Activity
November 18, 2025 04:13 PM AEDT| By SamExtensive analysis of Sonic Healthcare Limited’s diagnostic networks, laboratory capabilities, radiology services, scientific structure and wide-reaching role across major Australian healthcare indices.
CleanSpace Holdings and the All Ordinaries Amid a Shifting Commercial Equipment Landscape
November 17, 2025 05:09 PM AEDT| By SamCleanSpace Holdings’ recent operational update highlights themes surrounding manufacturing alignment, procurement cycles, and product distribution across safety-focused industries.
Recce Pharmaceuticals and the Evolving ASX 200 Landscape
November 17, 2025 01:16 PM AEDT| By SamRecce Pharmaceuticals reflects on the scientific legacy behind its technology platform, reinforcing its ongoing commitment to innovative anti-infective research within a dynamic Australian market landscape.
Bioxyne expands therapeutic footprint with new UK facility ASX 200
November 17, 2025 01:09 PM AEDT| By SamBioxyne expands its international therapeutic footprint through a new UK facility and evolving supply of regulated medicines, strengthening its presence across global alternative-treatment markets.
Race Oncology expands clinical programs with sector updates
November 17, 2025 01:06 PM AEDT| By SamRace Oncology expands programs in AML and lung cancer while progressing ongoing cardioprotection research and broader development planning.
Pro Medicus Moves Higher as Sector Interest Builds Across the ASX 200
November 17, 2025 11:53 AM AEDT| By SamPro Medicus gained early attention following a major enterprise contract, reinforcing confidence in cloud-based imaging solutions as broader ASX sectors observe steady engagement across technology, healthcare, and diversified market categories.
Trajan Group Holdings Faces Market Pressure Amid Shifting Sentiment ASX 200
November 17, 2025 10:54 AM AEDT| By SamTrajan Group Holdings navigates shifting market sentiment as observers reassess revenue momentum, sector context, and broader index movements influencing trade across the Australian market.
Pro Medicus Overview (ASX:PME) Across ASX 200 Healthcare Technology Landscape
November 14, 2025 06:47 PM AEDT| By SamExtensive overview of Pro Medicus, covering its enterprise imaging systems, workflow-technology operations, sector environment and representation across key ASX indices.
Australian Clinical Labs Overview (ASX:ACL) in the All Ordinaries Healthcare Landscape
November 14, 2025 06:35 PM AEDT| By SamAustralian Clinical Labs’ diagnostic operations, laboratory infrastructure, and sector activity, highlighting its position within the All Ordinaries index.
ASX 200 Update: Telix Pharmaceuticals (ASX:TLX) Drops as US Class Actions Mount
November 14, 2025 01:56 PM AEDT| By SamTelix Pharmaceuticals shares weakened after multiple US class actions alleged overstated progress on prostate cancer candidates and supply chain strength. The filings added pressure to a market already trading with softer sentiment.
ASX 200 Spotlight: Mach7 Technologies Faces Pressure as Revenue Trends Lag Sector Strength
November 14, 2025 12:15 PM AEDT| By SamMach7 Technologies’ valuation remains subdued as investors track revenue momentum against a rapidly expanding healthcare services sector. Market caution persists until growth consistency strengthens.
Sonic Healthcare’s Diagnostic Position Across the ASX 100 Healthcare Sector
November 13, 2025 08:54 PM AEDT| By SamSonic Healthcare’s diagnostic operations, laboratory capability, scientific programs and governance activity are highlighted through detailed sector-related information.
Arovella Therapeutics Lists New Securities on the ASX
November 13, 2025 11:32 AM AEDT| By SamArovella Therapeutics (ASX:ALA) has listed new securities on the ASX, reinforcing its biotechnology focus and supporting its ongoing therapeutic development goals within the evolving Australian market landscape.
Telix Pharmaceuticals Expands Healthcare Reach in ASX 200 Amid Biotech Advances
November 12, 2025 05:58 PM AEDT| By SamTelix Pharmaceuticals Limited (ASX:TLX) remains a vital player in the Australian biotechnology and healthcare industry, representing innovation within the ASX 200 through radiopharmaceutical advancements.
Telix Pharmaceuticals in ASX 200 Radiopharmaceutical Leadership in Australian Biotech
November 12, 2025 04:00 PM AEDT| By SamTelix Pharmaceuticals Limited, a key member of the ASX 200, develops diagnostic and therapeutic radiopharmaceuticals, supported by international manufacturing and research operations.
Advertise your brand on Kalkine Media